bromodeoxyuridine has been researched along with Carcinoma, Ductal, Breast in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baena-Cañada, JM; García-Olmedo, O; Jiménez-Bárcenas, R; Martínez, MJ; Muriel-Cueto, P | 1 |
| Jeong, BR; Kim, EO; Kim, ES; Kim, JG; Kim, YI; Lee, BJ; Min, YJ; Namgoong, IS; Park, JW | 1 |
| Ambs, S; Dorsey, TH; Frerich, K; Garza, JG; Glynn, SA; Hunt, KK; Johanning, GL; Li, M; Lin, K; Plummer, JB; Rycaj, K; Shen, J; Wang-Johanning, F; Yan, P; Yin, B | 1 |
| Chew, KL; Christov, K; Goodson, WH; Ljung, BM; Mayall, BH; Smith, HS; Waldman, FM | 1 |
| Hara, H; Hiroi, M; Moriki, T; Takahashi, T; Yamane, T | 1 |
| Hara, H; Hiroi, M; Kataoka, H; Moriki, T; Takahashi, T; Yamane, T | 1 |
| Chew, K; Chu, L; Isola, J; Kallioniemi, A; Nishizaki, T; Waldman, FM; Weidner, N | 1 |
| Reeve, LJ; Rew, DA; Wilson, GD | 1 |
| Archer, MC; Korkola, JE; Wood, GA | 1 |
1 review(s) available for bromodeoxyuridine and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Interaction between capecitabine and brivudin in a patient with breast cancer.
Topics: Aged; Anemia, Aplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Bromodeoxyuridine; Capecitabine; Carcinoma, Ductal, Breast; Combined Modality Therapy; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Interactions; Fatal Outcome; Female; Fluorouracil; Herpes Zoster; Humans; Onycholysis; Palliative Care; Peripheral Nervous System Diseases; Salvage Therapy; Stomatitis; Tooth Discoloration | 2010 |
8 other study(ies) available for bromodeoxyuridine and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Visfatin stimulates proliferation of MCF-7 human breast cancer cells.
Topics: Adipocytes; Adipokines; Adipose Tissue, White; Body Mass Index; Bromodeoxyuridine; Carcinoma, Ductal, Breast; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclins; Female; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Nicotinamide Phosphoribosyltransferase; Recombinant Proteins; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A | 2010 |
Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
Topics: Adult; Aged; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Ductal, Breast; Cell Line, Tumor; Endogenous Retroviruses; Enzyme-Linked Immunosorbent Assay; Feasibility Studies; Female; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Gene Products, env; Humans; Immunoblotting; Immunohistochemistry; Immunotherapy; In Situ Nick-End Labeling; Ki-67 Antigen; Mice; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Neoplasm Grading; Neoplasm Staging; Pilot Projects; Protein Array Analysis; Random Allocation; Retroviridae Proteins; Signal Transduction; Transplantation, Heterologous; Tumor Suppressor Protein p53; Up-Regulation | 2012 |
Cell proliferation in hyperplastic and in situ carcinoma lesions of the breast estimated by in vivo labeling with bromodeoxyuridine.
Topics: Adult; Aged; Breast; Breast Neoplasms; Bromodeoxyuridine; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cell Division; Female; Humans; Hyperplasia; Immunohistochemistry; Middle Aged; Neoplasm Invasiveness; Reference Values | 1994 |
Histological grade in invasive ductal carcinoma of breast correlates with the proliferative activity evaluated by BrdU: an immunohistochemical study including correlations with p53, c-erbB-2 and estrogen receptor status.
Topics: Adult; Aged; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Ductal, Breast; Cell Division; Evaluation Studies as Topic; Female; Humans; Immunohistochemistry; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Receptor, ErbB-2; Receptors, Estrogen; Tumor Suppressor Protein p53 | 1996 |
Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status.
Topics: Adult; Aged; Antigens, Nuclear; Biomarkers, Tumor; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Ductal, Breast; Cell Division; DNA; DNA Replication; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Receptor, ErbB-2; Receptors, Estrogen; Tumor Suppressor Protein p53 | 1996 |
Genetic alterations in lobular breast cancer by comparative genomic hybridization.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Bromodeoxyuridine; Cadherins; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chromosome Aberrations; DNA, Neoplasm; Female; Humans; Immunohistochemistry; Middle Aged; Nucleic Acid Hybridization | 1997 |
Comparison of flow and laser scanning cytometry for the assay of cell proliferation in human solid tumors.
Topics: Adenocarcinoma; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Ductal, Breast; DNA; Female; Flow Cytometry; Humans; Image Cytometry; Metaplasia; Stomach Neoplasms | 1998 |
Cyclin D1 expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat.
Topics: Animals; Bromodeoxyuridine; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Female; Immunohistochemistry; Mammary Neoplasms, Experimental; Methylnitrosourea; Precancerous Conditions; Rats; Rats, Inbred WF | 1999 |